Acelyrin
(NASDAQ) SLRN
Acelyrin Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$342.00K
Net Income (TTM)
$268.52M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SLRN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acelyrin
Industry
Biotechnology
Sector
Health CareEmployees
83
CEO
Mina Kim
Website
www.acelyrin.comHeadquarters
Agoura Hills, CA 91301, US
SLRN Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-426%
Net Income Margin
-393%
Return on Equity
-31%
Return on Capital
-35%
Return on Assets
-31%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$423.00K
Operating Income
$316.26M
EBITDA
$247.80M
Operating Cash Flow
$303.92M
Capital Expenditure
$1.25M
Free Cash Flow
$305.17M
Cash & ST Invst.
$447.88M
Total Debt
$6.27M
Acelyrin Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
83
N/A
Net Income
$55.26M
-58.0%
EBITDA
$59.74M
+27.8%
Quarterly Fundamentals
Net Cash
$404.62M
-40.3%
Accounts Receivable
$16.61M
+210.1%
Inventory
$0.00
-100.0%
Long Term Debt
$5.97M
+426.5%
Short Term Debt
$0.00
N/A
Return on Assets
-30.77%
N/A
Return on Invested Capital
-35.23%
N/A
Free Cash Flow
$38.96M
+32.1%
Operating Cash Flow
$38.95M
+32.0%